Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assessment of long-term antibody persistence after a booster dose of GSK Biologicals' Hib and meningococcal C vaccine (Menitorix) 471266 given at 12-15 months of age to subjects primed with 3 doses of Menitorix at 2, 3, 4 months of age.

Next Previous
X
Search
Trial Profile

Assessment of long-term antibody persistence after a booster dose of GSK Biologicals' Hib and meningococcal C vaccine (Menitorix) 471266 given at 12-15 months of age to subjects primed with 3 doses of Menitorix at 2, 3, 4 months of age.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Sep 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DTaP poliovirus vaccine (Primary) ; Hib-DTaP-poliovirus vaccine (Primary) ; Hib-meningococcal vaccine group C conjugate (Primary) ; Meningococcal vaccine group C conjugate (Primary) ; Hib vaccine conjugate; Measles mumps and rubella virus vaccine
  • Indications Diphtheria; Haemophilus infections; Meningococcal group C infections; Pertussis; Poliomyelitis; Tetanus
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors GlaxoSmithKline; GSK

    • Most Recent Events

    • 22 Sep 2011 Actual end date changed from Oct 2007 to May 2010 as reported by ClinicalTrials.gov.
    • 13 Jan 2010 Additional lead trial investigator identified as reported by United Kingdom Clinical Research Network.
    • 13 Jan 2010 New source identified and integrated (United Kingdom Clinical Research Network 7814).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top